Oral Vaccination: Disease Management for Aquaculture
Aquaculture is the future of sustainable food production. It is the world's fastest growing food sector, with an estimated worth of 200 billion USD, but every year, farmers face a crisis with managing disease, losing more than 10 billion USD worth of fish stocks annually. MicroSynbiotiX is developing cost-effective oral vaccines to combat these infections and improve global food security. We are developing a novel, patent-pending method of producing oral vaccines using transgenic microalgae. Our solution will make disease management much more sustainable and reduce the need for antibiotics.
Awards
Our Official Research Platform
|
"I think the project shows a lot of promise! The marketable applications in the US are significant."
-Alex Foster, M.B.A. Life Science Business Development Santa Clara University, Stanford University, University of California Santa Cruz 
|
|
"The team assembled has expertise from a wide variety of backgrounds and will be able to make big strides towards the overall goals of the project."
-Asif Rahman, Ph.D. Postdoctoral Research Fellow NASA Ames Research Center 
|
|
"This is a potentially transformative project with important implications for medicine and human health... I fully endorse Antonio and his collaborators, and I wish them much success."
-Jarmila Pitterman, Ph.D. Associate Professor University of California, Santa Cruz |
|
"Studying microalgae opens the door for producing therapeutics inexpensively and provides preliminary work for extra-planetary protein production!"
-Josiah Zayner, Ph.D. Synthetic Biologist, Biohacker The Open Discovery Institute 
|
R&D Partners
Our Supporters
